Contract Award For 44230303/Wqd/Supply And Delivery Of Chemicals For Research Purpose . S4...


Contract Award Notice

TRR 18148708
Organization Public Utilities Board
Tender No PUB000ETQ23000179
Funded By Self-Funded
Country Singapore , South Eastern Asia
Contract Value 14,702

Work Detail

Contract Award For 44230303/Wqd/Supply And Delivery Of Chemicals For Research Purpose . S4: Norethindrone-2,2,4,6,6,10-D6, Cas No: 2376036-05-2, 5 Mg/ Bottle, Purity Greater Than Or Equal To 98% Atom D , S4: 2,3,7,8-Tetrachlorodibenzo-P-Dioxin, Cas No: 1746-01-6, Mw: 321.97: Purity: 95%, 1Mg/Bottle , S4: 2-Endo,3-Exo,5-Endo,6-Exo,8,8,10,10-Octachlorobornane (Parlar 26), Cas No: 142534-71-2, 10 Ug/Ml In Nonane, 1Ml/Bottle , S4: 2-Endo,3-Exo,5-Endo,6-Exo,8,8,9,10,10-Nonachlorobornane (Parlar 50), Cas No: 6680-80-8, 10 Ug/Ml In Nonane, 1Ml/Bottle , S4: 2,2,5,5,8,9,9,10,10-Nonachlorobornane (Parlar 62), Cas No: 154159-06-5, 10 Ug/Ml In Nonane, 1Ml/Bottle , S4: Us Epa Method 8276 Toxaphene Composite Stock, Cil-Es-5543 Or Equivalent, 8 Compounds, 1000Ng/Ml In Nonane, 1Ml/Bottle , S4: Tetramethylammonium Hydroxide (Tmah) Solution, 25Wt.% In Methanol, 100Ml/Bot , S4: Atorvastatin-D5, Cas No: 222412-82-0, 1 Mg/Bot, Purity Purity Greater Than Or Equal To 98% , S2: Equilin-D4, Cas No: 285979-79-5, Purity Greater Than Or Equal To 98%, 10 Mg/ Bottle , S2: Equilenin-D3, Cas No: 56588-54-6, Purity Greater Than Or Equal To 98%, 5 Mg/ Bottle , S2: Amoxicillin-D4, Cas No: 26787-78-0, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Doxycycline-D3 Hyclate, Cas No: 24390-14-5, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Ciprofloxacin-D8, Cas No: 85721-33-1, Purity Greater Than Or Equal To 95%, 2.5 Mg/Bottle , S2: Erythromycin-13C-D3, Cas No: 959119-26-7, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Clarithromycin-N-Methyl-D3, Cas No: 959119-22-3, Purity Greater Than Or Equal To 97%, 5 Mg/Bottle , S2: Ceftriaxone-D3 Disodium Salt, Cas No: 1132650-38-4, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Cloxacillin-13C4 Sodium Salt, Cas No: 642-78-4, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Piperacillin-D5, Cas No: 61477-96-1, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Sulfamethoxazole-D4, Cas No: 1020719-86-1, Purity Greater Than Or Equal To 95%, 5 Mg/Bottle , S2: Efavirenz-D5, Cas No: 1132642-95-5, Purity Greater Than Or Equal To 95%, 0.5 Mg/Bottle , S2: Ganciclovir-D5, Cas No: 1189966-73-1, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Metronidazole-D3, Cas No: 83413-09-6, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Clindamycin-D3 Hydrochloride, Cas No: 1356933-72-6, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Aciclovir-D4, Cas No: 1185179-33-2, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Entecavir-D2, Cas No: 142217-69-4, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Lamivudine-13Cd2, Cas No 134678-17-4, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Abacavir-D4, Cas No: 1217731-56-0, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Cephalexin-D5 Hydrate, Cas No: 23325-78-2 Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Trimethroprim-D3, Cas No: 1189923-38-3 Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Tylosin 3-Acetate-D3, Cas No: 63409-10-9 Purity Greater Than Or Equal To 95%, 0.5Mg/Bottle , S2: Tetracycline-D6, Cas No: 60-54-8 Purity Greater Than Or Equal To 95%, 0.5Mg/Bottle , S2: Amoxicillin, Cas No: 26787-78-0, Purity Greater Than Or Equal To 97%, 250 Mg/Bot , S2: Azithromycin, Cas No: 83905-01-4, Purity Greater Than Or Equal To 97%, 100 Mg/Bot , S2: Ceftriaxone, Cas No: 73384-59-5, Purity Greater Than Or Equal To 97%, 100 Mg/Bot , S2: Clindamycin Hydrochloride, Cas No: 21462-39-5, Purity Greater Than Or Equal To 97%, 250 Mg/Bot , S2: Cloxacillin Sodium Salt, Cas No: 7081-44-9, Purity Greater Than Or Equal To 95%, 250 Mg/Bot , S2: Cefazolin, Cas No: 25953-19-9, Purity Greater Than Or Equal To 95 %, 250 Mg/Bot , S2: Entecavir, Cas No: 142217-69-4, Purity Greater Than Or Equal To 97%, 250 Mg/Bot , S2: Ganciclovir, Cas No: 82410-32-0, Purity Greater Than Or Equal To 97%, 100 Mg/Bot , S2: Lamivudine, Cas No: 134678-17-4, Purity Greater Than Or Equal To 97%, 100 Mg/Bot , S2: Abacavir, Cas No:136470-78-5, Purity Greater Than Or Equal To 95%, 100 Mg/Bot , S2: Azithromycin-13Cd3, Cas No: 83905-01-5, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: 1,4,7,14,17,20-Hexaoxacyclohexacosane-8,13,21,26-Tetrone, Cas No: 314254-68-7, Purity Greater Than Or Equal To 95%, 5Mg/Bot , S2: 3,6,9,16,19,22-Hexaoxabicyclo[22.3.1]Octacosa-1(28),24,26-Triene-2,10,15,23-Tetrone, Cas No: 1394013-66-1,Purity Greater Than Or Equal To 95%, 10Mg/Bot , S2: 3,6,9,17,20,23-Hexaoxatricyclo[23.3.1.1]Triaconta-1(29),11,13,15(30),25,27-Hexaene-2,10,16,24-Tetrone, Cas No: 94693-55-7, Purity Greater Than Or Equal To 95%, 10Mg/Bot , S2: Tris(1-Chloro-2-Propyl) Phosphate, Cas No: 13674-84-5, Purity Greater Than Or Equal To 95%, 250Mg/Bot , S2: 17Beta-Estradiol-D4, Cas 66789-03-5, Purity Greater Than Or Equal To 97%, 10Mg/ Bot , S2: 6Ppd-Quinone (6Ppd-Q), Cas No.:2754428-18-5, 100Mg/Bot , S4: Tylosin, Cas No: 1405-54-5, Purity Greater Than Or Equal To 95%, 250 Mg/Bot , S4: Metformin-D6 Hydrochloride, Cas No:1185166-01-1, 1 Mg/Bot, Purity Greater Than Or Equal To 98% , S4: Valsartan-D9, Cas No:1089736-73-1, 1Mg/Bot, Purity Greater Than Or Equal To 98% , S4: Glipizide-D11, Cas No:1189426-07-0, 1Mg/Bot, Purity Greater Than Or Equal To 98% , S4: Dicofol-D8, 1Mg/Bottle, Trc-D436701-1Mg Or Equivalent , S4: Rifampicin-D3, Cas No: 1262052-36-7, Purity Greater Than Or Equal To 95%, 0.5Mg/Bottle , S4: Cefazolin-13C215n Sodium Salt, Cas No: 1346602-30-9, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S4: 17-Beta-Estradiol, Cas No: 50-28-2, Mw: 321.97, Purity: 97%, 1G/Bottle , S1: Ciprofloxacin, Cas No: 85721-33-1, Purity Greater Than Or Equal To 97%, 100 Mg/Bot , S1: Erythromycin, Cas No: 114-07-8, Purity Greater Than Or Equal To 95%, 100 Mg/Bot , S1: Metronidazole, Cas No: 443-48-1, Purity Greater Than Or Equal To 97%, 250 Mg/Bot , S1: Piperacillin, Cas No: 66258-76-2, Purity Greater Than Or Equal To 97%, 100 Mg/Bot , S1: Rifampicin, Cas No: 13292-46-1, Purity Greater Than Or Equal To 95%, 100 Mg/Bot , S1: Tetracycline Hydrochloride, Cas No: 64-75-5, Purity Greater Than Or Equal To 97%, 250 Mg/Bot , S1: Trimethoprim, Cas No: 738-70-5, Purity Greater Than Or Equal To 98%, 250 Mg/Bot , S1: Efavirenz, Cas No:154598-52-4, Purity Greater Than Or Equal To 97%, 100 Mg/Bot , S1: 2-((4-Methylpentan-2-Yl)Amino)-5-(Phenylamino)Cyclohexa-2,5-Diene-1,4-Dione (6Ppd-Quinone) D5, Cas No: 2750119-14-1, 10Mg/Bot , S3: Mpfac-24Es, Mass-Labelled Pfas Extraction Standard Solution, 1000Ng/Ml, 1Ml/Bottle , S3: 2,3,3,3-Tetrafluoro-2-(1,1,2,2,3,3,3-Heptafluoropropoxy)-13C3-Propanoic Acid, (M3hfpo-Da Or Equivalent, 50Ug/Ml In Methanol, 1Ml/Bottle) , S3: Native Pfas Precision And Recovery Standard Solution In Methanol (30 Components), (Wellington: Pfac30par Or Equivalent), 1Ug/Ml In Methanol, 1Ml/Bottle , S3: Sodium Perfluoro-1-Dodecanesulfonate, Cas No: 1260224-54-1, 50Ug/Ml, 1Ml/Bottle (L-Pfdos Or Equivalent) , S3: Sodium Perfluoro-1-Undecanesulfonate, Cas No: 441296-91-9, 50Ug/Ml, 1Ml/Bottle (L-Pfuds Or Equivalent) , S3: Sodium Perfluoro-1-Tridecanesulfonate, Cas No: 174675-49-1, 50Ug/Ml, 1Ml/Bottle (L-Pftrds Or Equivalent) , S3: Native Perfluoroalkyl Ether Carboxylic Acid And Sulfonate Solution, Pfac-Mxg Or Equivalent, (Cas No: 377-73-1, 863090-89-5, 151772-58-6, 113507-82-7, 2000 Ng/Ml In Methanol, 1Ml/Bottle , S3: Perfluoro-4-Oxapentanoic Acid (Pfmpa), Cas No: 377-73-1, At Least 50Ug/Ml, 1Ml/Bottle (Pf4opea Or Equivalent) , S3: Perfluoro-5-Oxahexanoic Acid (Pfmba), Cas No: 863090-89-5, At Least 50Ug/Ml, 1Ml/Bottle (Pf5ohxa Or Equivalent) , S3: Nonafluoro-3,6-Dioxaheptanoic Acid (Nfdha), Cas No: 151772-58-6, At Least 50Ug/Ml, 1Ml/Bottle (3,6-Opfhpa Or Equivalent) , S3: Potassium Perfluoro(2-Ethoxyethane)Sulfonate (Pfeesa), Cas No: 113507-82-7, At Least 50Ug/Ml, 1Ml/Bottle (Pfeesa Or Equivalent) , S3: Mpfac-C-Is, Mass-Labelled Pfas Injection Standards, 2000Ng/Ml In Methanol, 1Ml/Bottle , S3: 6:2Ftab, Cas No: 34455-29-3, 50Ug/Ml, 1Ml/Bottle, N-Cmamp-6:2Fosa Or Equivalent , S3: 3-Perfluoropropyl Propanoic Acid (3:3) (Fprpa), Cas No: 356-02-5, At Least 50Ug/Ml, 1Ml/Bottle, Fprpa Or Equivalent , S3: 3-Perfluoropentyl Propanoic Acid(5:3) (Fpepa), Cas No: 914637-49-3, At Least 50Ug/Ml, 1Ml/Bottle, Fpepa Or Equivalent , S3: 3-Perfluoroheptyl Propanoic Acid(7:3) (Fhppa), Cas No: 812-70-4, At Least 50Ug/Ml, 1Ml/Bottle, Fhppa Or Equivalent , S3: N-Methyl Perfluorooctanesulfonamidoethanol, Cas No: 24448-09-7, At Least 50Ug/Ml, 1Ml/Bottle, N-Mefose-M Or Equivalent , S3: N-Ethyl Perfluorooctanesulfonamidoethanol, Cas No: 1691-99-2, At Least 50Ug/Ml, 1Ml/Bottle, N-Etfose-M Or Equivalent , S3: N-Methyl Perfluorooctanesulfonamide , Heptadecafluoro-N-Methyloctanesulphonamide, Cas No: 31506-32-8, At Least 50Ug/Ml, 1Ml/Bottle, N-Mefosa-M Or Equivalent , S3: N-Ethyl Perfluorooctanesulfonamide, Cas No: 4151-50-2, At Least 50Ug/Ml, 1Ml/Bottle, N-Etfosa-M Or Equivalent , S3: 10:2 Fluorotelomer Sulfonic Acid (10:2 Fts), Cas No: 108026-35-3, At Least 50Ug/Ml, 1Ml/Bottle, 10:2 Fts Or Equivalent , S3: Perfluoro-N-Hexadecanoic Acid (Pfhxda), Cas No: 67905-19-5, 50Ug/Ml, 1Ml/Bottle, Pfhxda Or Equivalent , S3: Perfluorooctadecanoic Acid, Cas No: 16517-11-6, At Least 50Ug/Ml, 1Ml/Bottle, Pfoda Or Equivalent , S3: Perfluorohexanesulfonic Acid, Cas No: 355-46-4, 50Ug/Ml, 1Ml/Bottle, Pfhxs Or Equivalent , S4: Doxycycline Hyclate, Cas No: 24390-14-5, Purity Greater Than Or Equal To 95%, 250 Mg/Bot , S4: Vancomycin-D12, Cas No: 1404-90-6 Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S4: Cefalexin Monohydrate, Cas No: 23325-78-2, Purity Greater Than Or Equal To 97%, 250 Mg/Bot , S4: Sulfamethoxazole, Cas No: 723-46-6, Purity Greater Than Or Equal To 97%, 250 Mg/Bot , S4: Aciclovir, Cas No: 59277-89-3, Purity Greater Than Or Equal To 97%, 250 Mg/Bot , S4: N-(1,3-Dimethylbutyl)-N-Phenyl-P-Phenylenediamine (6Ppd), Cas No: 793-24-8, 500Mg/Bot , S4: Valsartan, Cas No:137862-53-4, 10Mg/Bot, Purity Greater Than Or Equal To 98% , S4: Atorvastatin, Cas No: 134523-03-8, 5 Mg/Bot, Purity Greater Than Or Equal To 98% , S4: Clopidogrel Hydrogen Sulfate, Cas No:135046-48-9, 5Mg/Bot, Purity Greater Than Or Equal To 98% , S4: Glipizide, Cas No: 29094-61-9, 10Mg/Bot, Purity Greater Than Or Equal To 98% , S4: Tbtc (Tributyltin Chloride), Cas No: 1461-22-9, Product Code: Dre-C17150000 Or Equivalent, 250Mg/Bot , S4: Fentin-Chloride, Cas No: 639-58-7, Product Code: Dre-C13601000 Or Equivalent, 250Mg/Bot , S4: Dibutyltin-Dichloride, Cas No: 683-18-1, Product Code: Dre-C12258000 Or Equivalent, 250Mg/Bot , S4: Di-N-Octyltin Dichloride, Cas No: 3542-36-7, Product Code: Dre-C12837000 Or Equivalent,100Mg/Bot , S4: Clarithromycin, Cas No: 81103-11-9, Purity Greater Than Or Equal To 97%, 250 Mg/Bot , S4: 1,3-Di-O-Tolylguanidine, Cas No: 97-39-2, 100G/Bot , S4: (S)-(+)-Clopidogrel-D3 (Sulfate), 5Mg/Bot, Purity Greater Than Or Equal To 98% , S4: Ortho-Phosphoric Acid, 85%, Cas No: 7664-38-2, 2.5 L/Bot , S4: Brij 35 Solution, 30% W/W In Water, Cas No: 9002-92-0, 100 Ml/Bot , S4: Acetic Acid, Hplc Grade, Purity Greater Than Or Equal To 99.8%, In Glass Bottle, 100Ml/Bottle , S4: Vancomycin Hydrochloride, Cas No: 1404-93-9, Purity Greater Than Or Equal To 93%, 250 Mg/Bot , S4: Metformin, Cas No: 1115-70-4, 500 Mg/Bot, Purity Greater Than Or Equal To 97%

Key Dates

Contract Date 16 Apr 2024

Contact Information

Company Name Nareen Technologies Pte. Ltd.
Contract Value 14,702
Contract Date 16 Apr 2024

Complete details of the selected Tender
Organisation Name : Vijaya Bank
Organisation Type : Public Sector Banks Ministry : Ministry of Finance
Tender Ref. No : DIT/DELHIARMB/07052016/1
Tender Title : E-Auction Sale Notice for the properties of M/s Guru Kripa Iron Trading Pvt Ltd, mortgaged to Vijaya Bank and taken possession under the provisions of SARFAESI Act 2002.
Product Category : Land/Building
Sub Category :
Tender Value (INR if not mentioned):
Rs 1,62,00,000/-
EMD :
1620000
Document Cost :
0
Tender Type : Auction
Location : Delhi
First   
Announcement Date :
5-July-2016  
Publication Date on Portal: 5-July-2016 At : 8:03:09 PM  
Last Date of Document Collection :  
8-August-2016 Up To : 5:00 PM  
Last date for  
Submission :
8-August-2016 Up To : 5:00 PM  
Opening Date : 10-August-2016 At : 11:00 AM  
Work Description :
Pre-Qualification :
PreBid Meet Date : --
Tender Document : View Document *
Bid Document : Document Not available
Tech. Document : Document Not available
Sector : Banking, Finance & Insurance
State : Karnataka
 
For further Information Contact:
Name : Santhosh Aili
E-Mail : cbsprog11@vijayabank.co.in
Phone Office : 08025584066
Fax : 08025582747
Address :
City : Bangalore

  download Adobe® Reader®
Adobe® and Get Adobe® Reader® logo are trademarks or registered trademarks of Adobe Systems Inc. in the US and/or other countries.

View Notice Now...

Login with your Social Account for Instant Access to this notice


Tell us about your Product / Services,
We will Find Tenders for you